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Comparison Between Balloon-Assisted and 
Stent-Assisted Technique for Treatment of
Unruptured Internal Carotid Artery Aneurysms
Keun Young Park, MD2, 3, Byung Moon Kim, MD1, 3, Dong Joon Kim, MD1, 3
Purpose: To compare clinical and angiographic outcomes between balloon-assisted (BAC) and stent-
assisted coiling for internal carotid artery unruptured aneurysms (ICA-UA).
Materials and Methods: A total of 227 ICA-UA in 190 patients were treated with BAC (120 patients, 141
ICA-UA) or SAC (70 patients, 86 ICA-UA. We compared characteristics of patients and ICA-UA, and
clinical and angiographic outcomes between groups. 
Results: Aneurysm size and neck diameter were greater for SAC than in BAC, but aneurysm volume and
coil packing density were not different between groups. Immediate angiographic occlusion grade
was better for BAC than for SAC. Periprocedural thromboembolic events were more frequent dur-
ing SAC (11.6%) than BAC (2.4%) per aneurysm, but hemorrhagic events were the opposite (2.4%
for BAC and none for SAC per aneurysm) (p < 0.05). At discharge, treatment-related morbi-mortali-
ty rates were 1.6% for BAC and 1.4% per patient for SAC. At clinical follow-up (BAC, 118 patients
[98.3%] for a mean of 48.4 months; SAC, 69 patients [98.6%], for a mean of 37.4 months), 1 addi-
tional treatment-related infarction occurred during SAC, resulting in a modified Rankin scale score
of 4. Thus, overall treatment-related morbi-mortality rates were 1.7% in BAC and 2.9% in SAC. At
imaging follow-up (BAC, 135 aneurysms [95.7%] for 28.3 months; SAC, 81 aneurysms [94.1%] for
23.9 months), BAC and SAC showed stable or improved occlusion in 94.1% and 95.0%, minor recur-
rence in 4.4% and 2.5%, and major recurrence in 1.5% and 2.5%, respectively.
Conclusion: Both BAC and SAC were safe and effective techniques for ICA-UA. There were no differences
in morbi-mortality and recurrence rates between groups. 
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Endovascular coiling is the preferred treatment for
ruptured or unruptured intracranial aneurysms [1-4].
For treatment of internal carotid artery unruptured
aneurysms (ICA-UA), coiling is the more favored
treatment. On the other hand, balloon and stent are
representative of assistant devices for wide-neck
aneurysm coiling [5-14]. Both devices were more
frequently used for ICA-UA, because ICA is the largest
of the intracranial arteries and is easy to navigate. Each
device has its own strengths and drawbacks in coiling
of ICA-UA [9-14]. To date, there were no studies
comparing balloon-assisted (BAC) and stent-assisted
coiling for the treatment of ICA-UA. The purpose of
this study was to compare clinical and angiographic
outcomes between BAC and SAC for IAC-UA. 
PATIENTS AND METHODS
All ICA-UA that underwent BAC or SAC were
identified from prospectively maintained neurointer-
ventional databases in single academic tertiary referral
hospitals between January 2010 and July 2015. The
inclusion period was determined such that at least 1-
year clinical follow-up was available for patients at the
latest out-patient or telephone follow-up. The institu-
tional review board approved this retrospective study
with a waiver of informed consent for study inclusion.
All relevant clinical and imaging data were obtained
from electronic medical charts, a picture archive
system, and a prospectively registered neurointerven-
tional database. The clinical and angiographic
outcomes were retrospectively analyzed.
Coiling procedure 
Procedural details were previously described in the
literature [16, 17]. Briefly, all patients with unruptured
aneurysms who scheduled coil embolization received
dual antiplatelet premedication (aspirin 100 mg and
clopidogrel 75 mg) for at least 5 days. Dual antiplatelet
medication was maintained for at least 3 months and
then was changed to aspirin monotherapy for patients
receiving SAC. Dual antiplatelet medication was
stopped for patients receiving BAC. After introduction
of a guiding catheter, a bolus of heparin 3000 IU was
injected and then heparin 1000 IU was given as a
booster every hour. A 6-French shuttle guiding sheath
was placed in the relevant internal carotid artery. 
The adjunctive balloons used in this study were
Hyperform/Hyperglide (Covidien, Irvine, California)
and Scepter C balloons (Microvention, Tustin,
California). The stents used in this study included
Enterprise (Codman Neurovascular, Ratham,
Massachusetts), Neuroform (Stryker Neurovascular,
Fremont, California), and Solitaire AB (Covidien,
Irvine, California) stents. It depended on the operator’s
preference to choose which type of treatment, BAC or
SAC.  
Outcome measures
Treatment-related morbidity was def ined as the
development of any new neurological deficit due to
treatment-related complications that were still present
at discharge. Treatment-related mortality was defined
when the patient died from treatment-related complica-
tions during clinical follow-up. The clinical outcome at
the latest follow-up was defined as the final outcome.
If the latest clinical follow-up was more than 3 months
at the point of the analysis of this study, a telephone
interview was obtained to determine the patient’s
clinical status. 
Immediate post-coiling angiographic outcome was
analyzed according to Raymond’s grade, where class 1
means complete obliteration; class 2 means a residual
neck; and class 3 means a residual aneurysm [15]. 
Imaging follow-up was conducted with MR angiogra-
phy or catheter angiography. Follow-up angiographic
outcome was also analyzed to Raymond’s grade [15]
and was additionally classif ied into 3 categories:
improved/stable, minor recurrence when the recurred
aneurysm didn’t require re-treatment and major
recurrence when the recurred aneurysm required re-
treatment. The need for re-treatment was determined
based on discussion among 2 neurointerventionists and
3 vascular neurosurgeons in a weekly neurovascular
conference.
Statistical analysis
Statistical analysis performed using IBM SPSS
version 20. Each continuous variable was presented
with a mean SD and each categorical variable was
analyzed with an incidence and %. The unpaired t-test
was used for continuous variables with a normal distri-
bution and the Mann-Whitney U test was used for
continuous variables without a normal distribution. The
x2 test was used for categorical variables. Statistical
significance was determined as p-value < .05 within a
95% confidence interval.
RESULTS
A total of 227 ICA-UA in 190 patients were treated
with BAC (120 patients, 141 ICA-UA) or SAC (70
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patients, 86 ICA-UA). Five ICA-UA were initially BAC
but converted to SAC. Table 1 summarizes the charac-
teristics of patients and IC-UA, and immediate clinical
and angiographic outcomes. There were no differences
in age and gender between groups. Aneurysm size and
neck diameter were greater in SAC than in BAC, but
aneurysm volume and coil packing density were not
different between groups. Immediate angiographic
occlusion grade was better in BAC than in SAC.
Periprocedural thromboembolic events were more
frequent in SAC (11.6%) than in BAC (2.4%), but
hemorrhagic events were the opposite (2.4% for BAC
and none for SAC) (p < 0.05). At discharge, treatment-
related morbi-mortality rates were 1.0% in BAC and
0.5% in SAC. 
Table 2 summarizes clinical and angiographic follow-
up results. At clinical follow-up (BAC, 118 patients
[98.3%] for 48.4 months; SAC, 69 patients [98.6%], for
37.4 months), 1 additional treatment-related infarction
occurred in SAC, resulting in a modified Rankin scale
score of 4. Thus, overall treatment-related morbi-
mortality rates were 1.7% in BAC and 2.9% in SAC. At
imaging follow-up (BAC, 135 aneurysms [95.7%] for
28.3 months; SAC, 81 aneurysms [94.1%] for 23.9
months) with MR angiography (n=149) or catheter
angiography (n=67), BAC and SAC showed stable or
improved occlusion in 94.1% and 95.0%, minor
recurrence in 4.4% and 2.5%, and major recurrence in
1.5% and 2.5%, respectively. Table 3 summarizes
treatment-related symptomatic complications during
the procedure and follow-up periods. 
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Table 1. Characteristics of Patients and Aneurysms and Immediate Clinical and Angiographic Outcomes
Total BAC SAC P
Patient, n (%) 190 120 70
Age, mean years (SD) 54.4 9.9 53.7 9.8 55.6 9.90 NS
Female 164 (86.3%) 104 60 NS
No, of aneurysms 227 141 (62.1%) 86 (37.9%)
Location at ICA NS
Hypophyseal-ophthalmic-paraclinoid, 167 (73.6%) 099 (70.2%) 68 (79.1%)
Pcom 039 (17.2%) 026 (18.4%) 13 (15.1%)
AChoA 12 (5.3%) 12 (8.5%) 0
ICA bifurcation 09 (3.9%) 04 (2.8%) 05 (5.8%)0
Dome diameter, mm 5.0 1.9 4.8 2.1 5.6 2.0 < 0.01
Neck diameter, mm 3.7 1.3 3.3 1.0 4.4 1.5 < 0.01
Dome-to-Neck ratio 1.1 0.4 1.2 0.4 0.9 0.4 < 0.01
Sac volume, mm3 51.2 62.6 53.7 0.80 56.5 51.8 NS
Packing density (%) 37.4 13.9 37.5 12.9 37.3 15.0 NS
Immediate Raymond grade 0< 0.022
1 114 (50.2%) 073 (51.8%) 41 (47.7%)
2 081 (35.7%) 055 (39.0%) 26 (30.2%)
3 032 (14.1%) 013 (9.2%)0 19 (22.1%)
Periprocedural events (n=227) 0< 0.018
Any thromboembolic 13 (5.7%) 03 (2.4%) 10 (11.6%)
Any hemorrhagic 03 (1.3%) 03 (2.4%) 0
Treatment-related morbidity and mortality 03 (1.6%) 02 (1.6%) 01 (1.4%)0 NS
at discharge (n=190)
BAC = balloon-assisted coiling, SAC = stent-assisted coiling, ICA = internal carotid artery, Pcom = posterior communicating artery,
AchoA = anterior choroidal artery, NS = not significant. 
DISCUSSION
In this study, both BAC and SAC were safe and
effective techniques for ICA-UA. Treatment-related
morbidity and mortality rates during periprocedural
and follow-up periods were very low without a signifi-
cant difference between groups. Furthermore,
recurrence rates were also very low in both groups
without a significant difference between groups.
Both balloon and stent are representative of assistant
devices for wide-neck aneurysm coiling [5-14].
Although each device has its own strengths and
drawbacks in coiling of ICA-UA, each device was
frequently used for ICA-UA because ICA is the largest
of the intracranial arteries and is easy to navigate.
However, to date, there exists no study in the literature
to compare outcomes between BAC and SAC for
coiling of ICA-UA. This is, to our knowledge, the first
study to compare BAC and SAC selectively for ICA-
UA coiling for a relatively large number of subjects. 
In this study, almost all patients and ICA-UA
underwent clinical and imaging follow-up. The
recurrence rate is quite lower than reported in the litera-
ture. Furthermore, a majority of ICA-UAs showed an
improving occlusion grade for both groups (Table 2).
This is likely due to most ICA-UAs being small (mean
aneurysm size, 5.0 mm). Another explanation is that
most ICA-UAs are of the side-wall type, except for
ICA-UAs at the Pcom origin and ICA bifurcation,
which was responsible for only 21% of all ICA-UAs. 
With respect to treatment-related complications, it is
noteworthy that there was a significant difference in the
type of complications between BAC and SAC.
Treatment-related thromboembolic events were more
frequent for SAC, whereas treatment-related
hemorrhagic events were more common for BAC
(Table 1). Furthermore, the 2 symptomatic complica-
tions in BAC were due to hemorrhagic one during the
periprocedural period, whereas the 2 symptomatic
complications in SAC were both ischemic. One of the 2
ischemic complications occurred during periprocedural
and the other occurred 18 months after the treatment
(Table 3). 
This study has some limitations inherent to its
retrospective nature. Clinical outcome cannot be
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Table 2. Follow-up Clinical and Angiographic Outcomes
Total BAC SAC P
Clinical f-u, n (%) 187 (98.4%) 118 (98.3%) 69 (98.6%) NS
Clinical f-u period, months 44.3 18.9 48.4 17.8 37.4 19.1 < 0.001 <
Symptomatic thromboembolic, periprocedural 02 (1.1%) 0 2 (2.9%) NS
and f-u period
Symptomatic hemorrhagic, 02 (1.1%) 02 (1.7%) 0 NS
periprocedural and f-u period
Treatment-related morbidity and mortality at the 04 (2.2%) 02 (1.7%) 2 (2.9%) NS
latest f-u
Imaging f-u (n=227) 216 (95.2%) 135 (95.7%) 81 (94.1%) NS
Imaging f-u period, mean SD, months 26.6 14.9 28.3 15.9 23.9 12.6 0.028
Fu occlusion grade 0.009
Raymond 1 174 (80.6%) 106 (78.5%) 68 (83.9%)
2 032 (14.8%) 026 (19.3%) 6 (7.4%)
3 10 (4.6%) 03 (2.2%) 7 (8.6%)
Imaging fu results NS
Stable or improved 204 (94.4%) 127 (94.1%) 77 (95.0%)
Minor recurrence 08 (3.7%) 06 (4.4%) 2 (2.5%)
Major recurrence 04 (1.9%) 02 (1.5%) 2 (2.5%)
BAC = balloon-assisted coiling, SAC = stent-assisted coiling, ICA = internal carotid artery, Pcom = posterior communicating artery,
AchoA = anterior choroidal artery, NS = not significant, F-u = follow-up
compared at the same time, that is, at 3 months or at 12
months. The majority of imaging follow-up was
conducted with MR angiography, which may
potentially decrease the recurrence rate, especially in
SAC. However, the results of this study may provide
neurointerventionalists with helpful information
regarding their daily practice in that this study was first
to compare BAC and SAC for treatment specifically of
ICA-UAs, in which both types of coiling techniques are
frequently used. In addition, because 98.4% of the
patients were clinically followed-up for a mean of 44
months and 95.2% of ICA-UAs received imaging
follow-up for a mean of 26 months, the results of this
study may be reliable, even though they are retrospec-
tive. 
CONCLUSION
Both BAC and SAC were safe and effective
techniques for ICA-UA. There were no differences in
morbi-mortality and recurrence rates between groups.
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Table 3. Treatment-related Symptomatic Complications During the Procedure and follow-up Periods
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4 F/65 ICA Pcom 4.3 SAC Enterprise, 4.5/22 Ipsilateral MCA infarction 18 months after SAC 4
Tx = treatment type, F-u = follow-up, mRS = modified Rankin scale core, BAC = balloon-assisted coiling, SAC = stent-assisted coiling,
ICA = internal carotid artery, Pcom = posterior communicating artery.
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